osimertinib

KRAS proto-oncogene, GTPase ; Rattus norvegicus







2 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33246030 Dysregulated miR-137 and its target EGFR contribute to the progression of pituitary adenomas. 2021 Jan 15 1
2 34145930 Trametinib overcomes KRAS-G12V-induced osimertinib resistance in a leptomeningeal carcinomatosis model of EGFR-mutant lung cancer. 2021 Sep 3